CVS Health (CVS)
(Delayed Data from NYSE)
$56.94 USD
+0.47 (0.83%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$56.94 USD
+0.47 (0.83%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $108.04, marking a -0.48% move from the previous day.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $107.23, moving -0.15% from the previous trading session.
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS, WBA and RAD are likely to gain the most. However, reimbursement challenges are hurting the industry's health.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $107.11, moving +0.12% from the previous trading session.
Anthem (ANTM) to be Renamed as Elevance Health for Rebranding
by Zacks Equity Research
Anthem (ANTM) intends to rename itself as Elevance Health to solidify its position in the market that goes beyond traditional insurance products.
Why Is CVS Health (CVS) Down 1.2% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $103.60 in the latest trading session, marking a +1.21% move from the prior day.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
Here's Why You Should Retain CVS Health (CVS) Stock for Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on continued growth in its consumer-centric digital solutions.
Top Research Reports for Walmart, Exxon Mobil & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Exxon Mobil Corporation (XOM), and Thermo Fisher Scientific Inc. (TMO).
Market Futures Higher Ahead of Opening
by Zacks Equity Research
Market Futures Higher Ahead of Opening
Markets Stampede into the Green; CVS, GSK Beat, YUM Mixed
by Mark Vickery
Seeing our economy gaining in growth is a good reason for investors to become a little less risk-averse.
CVS Health (CVS) Q4 Earnings Beat Estimates, Margins Up
by Zacks Equity Research
Strength in all three operating segments drove CVS Health's (CVS) revenues in the fourth quarter of 2021.
Is Build-A-Bear (BBW) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Here is how Build-A-Bear (BBW) and CVS Health (CVS) have performed compared to their sector so far this year.
CVS Health (CVS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 2.06% and 0.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's How Investors Can Find Strong Retail and Wholesale Stocks with the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
CVS Health (CVS) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $108.72 in the latest trading session, marking a -0.17% move from the prior day.
Top Research Reports for Chevron, HSBC & Anthem
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), HSBC Holdings plc (HSBC), and Anthem, Inc. (ANTM).
CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Q4 Earnings to Gain From COVID Vaccine Sales
by Zacks Equity Research
CVS Health (CVS) is expected to have seen a significant part of its specialty orders being placed digitally through Q4 months, with growth drivers being COVID testing, vaccines and omni-channel.
AutoZone and National Beverage Corp. highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
AutoZone and National Beverage Corp. highlighted as Zacks Bull and Bear of the Day.
CVS Health (CVS) Hits a 52-Week High: What's Driving It?
by Zacks Equity Research
Strength across the retail segment and growing specialty pharmacy revenues are driving CVS Health's (CVS) top line.
Fortune Brands (FBHS) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Fortune Brands' (FBHS) Q4 earnings are likely to have gained from strength across its plumbing and security businesses. Supply chain constraints and cost inflation might have dragged its margins.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $106.79, moving +1.84% from the previous trading session.